Aptamer-based theranostic approaches for treatment of cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aptamer-based theranostic approaches for treatment of cancer

Published:2023 Issue: Volume: Page:433-454
ISSN:
Container-title:Aptamers Engineered Nanocarriers for Cancer Therapy
language:
Short-container-title:

Author:

Shahriari Mahsa,Kesharwani Prashant,Sahebkar Amirhossein

Publisher

Elsevier

Reference82 articles.

1. Cancer statistics, 2021;Siegel;CA: A Cancer Journal for Clinicians,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: A Cancer Journal for Clinicians,2021

3. Cancer statistics for the year 2020: an overview;Ferlay;International Journal of Cancer,2021

4. Cancer development, progression, and therapy: an epigenetic overview;Sarkar;International Journal of Molecular Sciences,2013

5. Ovarian cancer: diagnosis and treatment;Burges;Deutsches Ärzteblatt International,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

2. A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient;Scientific Reports;2024-01-29

3. Aptamer-based Theranostics in Oncology: Design Strategies and Limitations;BIO Integration;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP